Industry News
New computer program can help uncover hidden genomic alterations that drive cancers
4/19/2016
Tested on large tumor genomics database, REVEALER method allows researchers to connect genomics to cell function. Cancer is rarely the result of a single mutation in a single gene.
Newly discovered vulnerability in breast tumor cells points to new cancer treatment path
4/19/2016
Cancer cells often devise ways to survive even in the presence of toxic chemotherapy.
Cost-effectiveness of HPV vaccination
4/18/2016
Researchers report the economic and health impacts of a vaccine against human papilloma virus (HPV) in the United States.
Among patients with early-stage breast cancer who were considered at high risk for disease recurrence based on clinical and biological criteria, the MammaPrint genetic test identified a large group...
Palliative care viewed as a stigma, despite improving quality of life for cancer outpatients
4/18/2016
The term palliative care carries a stigma for patients and their caregivers, who regard it as synonymous with impending death.
Melanoma onset delayed with SPF30 sunscreen use
4/18/2016
In a mouse model of melanoma skin cancer, researchers found that the application of SPF30 sunscreen delayed the onset of the disease and reduced tumor incidence.
The demand for radiotherapy across all European countries will increase by an average of 16% between 2012 and 2025, with the highest expected increase being for prostate cancer cases (24%)...
Scientists identify compounds that may enhance antitumor activity of vitamin D
4/18/2016
Roswell Park Cancer Institute (RPCI) research on the most potent form of vitamin D, commonly called calcitriol, offers new insights into approaches that may enhance the antitumor activity of this...
Report identifies considerations for alternative payment models for cancer care
4/18/2016
A roundtable convened by the Turning the Tide Against Cancer initiative, composed of a multidisciplinary group of stakeholders, put forth five policy considerations that are critical to ensuring...
New findings by UCLA and Caltech could prevent drug resistance in people with brain cancer
4/18/2016
UCLA and Caltech researchers have developed a technique that shows promise for preventing drug resistance in people with glioblastoma, the most common and deadliest type of brain cancer.